Skip to main content
. 2021 Aug;10(8):3772–3787. doi: 10.21037/tcr-21-1240

Figure 1.

Figure 1

DLX6-AS1 was overexpressed in NSCLC tissues and cells and associated with a lower overall survival rate of NSCLC patients. (A) The RT-qPCR assay was conducted to detect the expression of DLX6-AS1 in 33 pairs of NSCLC tissues and adjacent normal tissues. (B) Kaplan-Meier survival analysis of overall survival for the 33 NSCLC patients with DLX6-AS1 expression level in tumor tissues. (C) RT-qPCR detected the expression of DLX6-AS1 in 16HBE, A549, and H1299 cells. *, P<0.05. DLX6-AS1, distal-less homeobox 6 antisense RNA 1; NSCLC, non-small cell lung cancer; RT-qPCR, reverse transcription-quantitative PCR.